Fitzcharles, Mary-Ann http://orcid.org/0000-0002-1091-3175
Petzke, Frank http://orcid.org/0000-0003-3265-8889
Tölle, Thomas R. http://orcid.org/0000-0003-4470-5531
Häuser, Winfried http://orcid.org/0000-0002-3742-729X
Article History
Accepted: 1 September 2021
First Online: 20 November 2021
Declarations
:
: None.
: MAF, FP and WH have no financial conflicts of interest to declare. MAF is the head of a task force of the Canadian Association of Rheumatology of a position paper on medical cannabis for rheumatic diseases; core member of Health Canada Science Advisory Committee on Health Products Containing Cannabis WH is the head of EFIC’s task force of a position paper on cannabis-based medicines and medical cannabis for chronic pain and member of the task force of the German Pain Society on the same topic. FP is the head of the task force of the German Pain Society of a position paper on cannabis-based medicines and medical cannabis for chronic pain. TT has received honoraria for consultancies, travel grants and speaking fees for AOP Orphan, Almiral Hermal, Bionest Partners, Benkitt Renkiser, Grünenthal, Hexal, Indivior, Kaia Health, Lilly, Medscape, Mundipharma, MSD, Novartis, Pfizer, Recordati Pharma, Sanofi-Aventis, and TAD Pharma.
: Not applicable
: Not applicable
: All authors participated in writing the manuscript.